Houlihan Lokey

Mark Francis
Managing Director
Head of the Healthcare Group
MFrancis@HL.com
214.220.8484

Karan Garg
Managing Director
Healthcare Group
KGarg@HL.com
312.456.4758

Eric Weldzius
Senior Vice President
Healthcare Group
EWeldzius@HL.com
312.462.6487

Tom Creegan
Vice President
Healthcare Group
TCreegan@HL.com
312.456.4727

Houlihan Lokey is a Leading Advisor to Premier Orthopedic Platforms

Physician practice management is a significant component of our healthcare franchise, and we are pleased to provide an update on our recent accomplishments in the orthopedic sector.

These transactions highlight Houlihan Lokey’s continued leadership in the broader physician practice management and multisite healthcare sectors, having closed more than 40 transactions in this space since 2016, including 12 transactions over the past 12 months.

August 2019
	The CORE Institute (dba HOPCo) is a vertically integrated provider of musculoskeletal care services with 270 providers across a network of more than 40 clinics, spine centers, and ASCs in Arizona, Michigan, and Florida. HOPCo’s IT platforms and standardized protocols help to achieve the triple aim of reducing cost, improving outcomes, and enhancing patient satisfaction.
July 2019
	A leading multispecialty orthopedic and neurosurgery physician group with three locations in Greenwich, Stamford, and Harrison. Provides the full continuum of high-quality musculoskeletal care with a clinical team composed of more than 60 providers.
November 2017
	The leading orthopedic practice in North Central Florida that provides the full spectrum of comprehensive, patient-centric musculoskeletal care through a network of six clinical locations and two physician-owned ASCs. The company’s comprehensive model for care is administered by 33 highly trained physicians.

Houlihan Lokey's Healthcare Group is among the largest dedicated healthcare investment banking groups in the country. In 2018, Houlihan Lokey was ranked the No. 1 M&A advisor for all U.S. healthcare transactions by Thomson Reuters.

For more information on our services and sector insights, please contact a member of the Houlihan Lokey Healthcare Group or visit HL.com.

Contacts

* * * * * * *

Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is ranked as the No. 1 M&A advisor for all U.S. transactions, the No. 1 global restructuring advisor, and the No. 1 global M&A fairness opinion advisor over the past 20 years, according to Thomson Reuters.

HL.com
Houlihan Lokey is a trade name for Houlihan Lokey, Inc., and its subsidiaries and affiliates, which include those in (i) the United States: Houlihan Lokey Capital, Inc., an SEC-registered broker-dealer and member of FINRA (www.finra.org) and SIPC (www.sipc.org) (investment banking services); Houlihan Lokey Financial Advisors, Inc. (financial advisory services); HL Finance, LLC (syndicated leveraged finance platform); and Houlihan Lokey Real Estate Group, Inc. (real estate advisory services); (ii) Europe: Houlihan Lokey EMEA, LLP and Houlihan Lokey (Corporate Finance) Limited, authorized and regulated by the U.K. Financial Conduct Authority; Houlihan Lokey S.p.A.; Houlihan Lokey GmbH; Houlihan Lokey (Netherlands) B.V.; and Houlihan Lokey (España), S.A.; (iii) the United Arab Emirates, Dubai International Financial Centre (Dubai): Houlihan Lokey (MEA Financial Advisory) Limited, regulated by the Dubai Financial Services Authority for the provision of advising on financial products, arranging deals in investments, and arranging credit and advising on credit to professional clients only; (iv) Singapore: Houlihan Lokey (Singapore) Private Limited, an “exempt corporate finance adviser” able to provide exempt corporate finance advisory services to accredited investors only; (v) Hong Kong SAR: Houlihan Lokey (China) Limited, licensed in Hong Kong by the Securities and Futures Commission to conduct Type 1, 4, and 6 regulated activities to professional investors only; (vi) China: Houlihan Lokey Howard & Zukin Investment Consulting (Beijing) Co., Limited (financial advisory services); (vii) Japan: Houlihan Lokey K.K. (financial advisory services); and (viii) Australia: Houlihan Lokey (Australia) Pty Limited (ABN 74 601 825 227), a company incorporated in Australia and licensed by the Australian Securities and Investments Commission (AFSL number 474953) in respect of financial services provided to wholesale clients only. In the European Economic Area (EEA), Dubai, Singapore, Hong Kong, and Australia, this communication is directed to intended recipients, including actual or potential professional clients (EEA and Dubai), accredited investors (Singapore), professional investors (Hong Kong), and wholesale clients (Australia), respectively. Other persons, such as retail clients, are NOT the intended recipients of our communications or services and should not act upon this communication. This email is an advertisement from Houlihan Lokey. To opt-out from receiving marketing communications from Houlihan Lokey and to manage your preferences in relation to the communications that Houlihan Lokey sends you, click here. Written inquiries can be sent to 10250 Constellation Blvd., 5th Fl., Los Angeles, CA 90067, or you may reach us via our contact page.

CONTACT US TERMS OF USE PRIVACY